GLP-1 drugs like tirzepatide and semaglutide offer powerful weight-loss effects but come with unanswered questions about long-term safety, side effects, and global accessibility. Researchers stress ...
Businesses were cautiously optimistic in the fall of 2023 when Governor Newsom signed a package of PAGA reforms described as a “big win” for employers. But with a full-year of data now available to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback